In our latest Asia Monthly, we discuss the performance of major Asian credit indices and review UST curve movements in July 2025. We also provide a recap of major news and macroeconomic releases, including those from the US, China, India, Indonesia and Japan. In addition, we summarise the top/bottom performers, recent USD bond issuances and rating actions in Asian corporate credit, as well as a list of our recent research. The Asia Monthly publication serves to keep investors updated on deve...
Following a disciplined acquisition strategy and diversification of its portfolio, MEDC established a sustainable oil and gas company. This approach enabled MEDC to achieve ROE of 19% in 2024, above its regional peers’ average of 9.6%. Its stake in Amman minerals will be a key catalyst for growing its net profit in 2026. It trades at consensus 6.3x PE 2025F, vs peers trading at 9.2x PE 2025F, which is a discount considering its ROE is the highest.
Results ASMPT (522 HK/BUY/HK$63.20/Target: HK$92.40): 2Q25: Results largely in line. Solid bookings beat as mainstream tools recover; AP tools progressing well in logic and at HBM clients. Update Prudential (2378 HK/BUY/HK$98.10/Target: HK$128.00): 1H25 results preview: Expecting solid NBP growth and focusing on capital management. INDONESIA Small/Mid Cap Highlights Medco Energi Internasional (MEDC IJ/NOT RATED/Rp1,260): Disciplined strategy and portfolio diversification. MALAYSIA Update CIMB ...
In our latest Asia Monthly, we discuss the performance of major Asian credit indices and review UST curve movements in June 2025. We also provide a recap of major news and macroeconomic releases, including those from the US, China, India, Indonesia and Japan. In addition, we summarise the top/bottom performers, recent USD bond issuances and rating actions in Asian corporate credit, as well as a list of our recent research. The Asia Monthly publication serves to keep investors updated on deve...
Oil prices have increased 14% over the past two weeks to US$71.30/barrel currently with a rising number of market participants and increasing oil long positions. However, UOB GEMR maintains a cautious stance and refrains from making any knee-jerk adjustments to its Brent oil forecast, with prices projected to remain at US$65/barrel in 3Q25 and US$60/barrel in 4Q25. That said, we highlight several stocks that could benefit if the rise in oil prices is sustained.
In our latest Asia Monthly, we discuss the performance of major Asian credit indices and review UST curve movements in May 2025. We also provide a recap of major news and macroeconomic releases, including those from the US, China, India, Indonesia and Japan. In addition, we summarise the top/bottom performers, recent USD bond issuances and rating actions in Asian corporate credit, as well as a list of our recent research. The Asia Monthly publication serves to keep investors updated on devel...
Medco Energi has announced a cash tender offer to repurchase up to all the outstanding USD 242.3 mn MEDCIJ 7.375 '26s and USD 418.7 mn MEDCIJ 6.375 '27s. It is also concurrently seeking to issue new USD 400 mn 5NC2 notes. In our view, the proposed transactions demonstrate Medco’s proactive management of its debt maturity profile. This comes after the company carried out two tender offers for the 2026 and 2027 notes in May and October 2024. We recommend holders of the MEDCIJ 7.375 '26s to...
In our latest Asia Monthly, we discuss the performance of major Asian credit indices and review UST curve movements in April 2025. We also provide a recap of major news and macroeconomic releases, including those from the US, China, India, Indonesia and Japan. In addition, we summarise the top/bottom performers, recent USD bond issuances and rating actions in Asian corporate credit, as well as a list of our recent research. The Asia Monthly publication serves to keep investors updated on dev...
The Asia Trade Book for April 2025 includes a summary of our recommendations, as well as our high-conviction ideas. The report also features relative-value charts and lists of the bonds across Asia HY and crossover credits. Please reach out to our analysts to discuss any of these ideas, or other trade recommendations from our Asia coverage.
Medco Energi's performance remained robust in FY 2024, with the company reporting stable earnings but improved cash flows. FCF was positive and net debt declined, supported by the disposal of Medco's Vietnamese assets. Consolidated Net Debt/EBITDA was healthy at 2.3x. Liquidity is sound. The company continues to sell c. 50% of total production based on fixed-price gas contracts, which will protect it against oil price volatility to a degree. We also note positively that Medco’s sizeable equi...
In our latest Asia Monthly, we discuss the performance of major Asian credit indices and review UST curve movements in March 2025. We also provide a recap of major news and macroeconomic releases, including those from the US, China, India, Indonesia and Japan. In addition, we summarise the top/bottom performers, recent USD bond issuances and rating actions in Asian corporate credit, as well as a list of our recent research. The Asia Monthly publication serves to keep investors updated on dev...
In our latest Asia Monthly, we discuss the performance of major Asian credit indices and review UST curve movements in February 2025. We also provide a recap of major news and macroeconomic releases, including those from the US, China, India, Indonesia and Japan. In addition, we summarise the top/bottom performers, recent USD bond issuances and rating actions in Asian corporate credit, as well as a list of our recent research. The Asia Monthly publication serves to keep investors updated on ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.